Suppr超能文献

口腔鳞状细胞癌中的纤溶酶原激活物系统

Plasminogen activator system in oral squamous cell carcinoma.

作者信息

Baker E A, Leaper D J, Hayter J P, Dickenson A J

机构信息

Clinical Research Scientist, Professorial Unit of Surgery, University Hospital of North Tees, Stockton on Tees, UK.

出版信息

Br J Oral Maxillofac Surg. 2007 Dec;45(8):623-7. doi: 10.1016/j.bjoms.2007.04.021. Epub 2007 Jun 21.

Abstract

BACKGROUND

The plasminogen activator system consists of two plasminogen activators, urokinase (uPA) and tissue (tPA); PA inhibitors (PAI-1, and -2), and a cell surface receptor for uPA (uPAR). The plasminogen activator system is involved at many stages of the metastatic cascade, including matrix remodelling, cell proliferation, and migration.

AIMS

To compare tissue concentrations of the components of the plasminogen activator system in paired tumour tissue and normal tissue in patients with oral squamous cell carcinoma, and to correlate these with the histopathological grading of the tumour.

METHODS

Thirty-eight paired tissue samples were analysed by enzyme-linked immunosorbent assays (ELISA; ng/mg protein) for uPA, tPA, uPAR, PAI-1, and PAI-2.

RESULTS

Concentrations of uPA, uPAR, PAI-1, and PAI-2 were significantly higher in tumour than in normal oral tissue (median in uPAR tumour 1.6 (range; 0.1-7.5) ng/mg protein; normal=0.2 (0-2.3), p<0.05). There were strong correlations between the concentrations of certain components of the plasminogen activator system in particular between uPA, uPAR, and PAI-1 (p<0.05). Tissue concentrations of some components of the plasminogen activator system correlated with clinical and pathological indexes of aggression of tumours, including differentiation and T-stage.

CONCLUSION

The relation between components of the plasminogen activator system, in particular uPA, uPAR, and PAI-1 in invasion, metastasis, prognosis, and survival, requires further investigation in oral squamous cell carcinomas.

摘要

背景

纤溶酶原激活物系统由两种纤溶酶原激活物,即尿激酶(uPA)和组织型纤溶酶原激活物(tPA);纤溶酶原激活物抑制剂(PAI - 1和PAI - 2),以及uPA的细胞表面受体(uPAR)组成。纤溶酶原激活物系统参与转移级联反应的多个阶段,包括基质重塑、细胞增殖和迁移。

目的

比较口腔鳞状细胞癌患者配对的肿瘤组织和正常组织中纤溶酶原激活物系统各成分的组织浓度,并将这些浓度与肿瘤的组织病理学分级相关联。

方法

采用酶联免疫吸附测定法(ELISA;纳克/毫克蛋白质)对38对组织样本进行uPA、tPA、uPAR、PAI - 1和PAI - 2的分析。

结果

肿瘤组织中uPA、uPAR、PAI - 1和PAI - 2的浓度显著高于正常口腔组织(uPAR肿瘤组织中位数为1.6(范围:0.1 - 7.5)纳克/毫克蛋白质;正常组织为0.2(0 - 2.3),p<0.05)。纤溶酶原激活物系统某些成分的浓度之间存在强相关性,特别是uPA、uPAR和PAI - 1之间(p<0.05)。纤溶酶原激活物系统某些成分的组织浓度与肿瘤侵袭的临床和病理指标相关,包括分化程度和T分期。

结论

纤溶酶原激活物系统各成分之间的关系,特别是uPA、uPAR和PAI - 1在口腔鳞状细胞癌的侵袭、转移、预后和生存中的关系,需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验